Molecular genetics of cerebrotendinous xanthomatosis in Jews of north African origin
- PMID: 8014582
Molecular genetics of cerebrotendinous xanthomatosis in Jews of north African origin
Abstract
Cerebrotendinous xanthomatosis (CTX) is an autosomal recessive sterol storage disease characterized by the accumulation of a bile alcohol, cholestanol, in diverse tissues. The disorder is manifested by extensive nervous system involvement, juvenile cataracts, tendon xanthomas, and premature atherosclerosis and is caused by sterol 27-hydroxylase (EC 1.14.13.15) mutations. Recently, two mutations were shown to cause CTX in four Jewish families of Moroccan origin. An additional mutant allele, found in a Jewish family of Algerian origin is characterized here. Sequence analysis revealed a C to T transition at cDNA position 1037 which predicted a threonine to methionine substitution at residue 306 (designated T306M). It is highly suggestive, but not definitive, that this transition is the mutation causing CTX in this family. A search for additional cases from Jewish families of North African extraction identified five new families including 10 cases. The three sterol 27-hydroxylase gene mutations account for all 10 CTX families and their presence may suggest the existence of positive selective forces that lead to an increased prevalence of this relatively rare disease in Jews from North Africa.
Similar articles
-
Frameshift and splice-junction mutations in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis in Jews or Moroccan origin.J Clin Invest. 1993 Jun;91(6):2488-96. doi: 10.1172/JCI116484. J Clin Invest. 1993. PMID: 8514861 Free PMC article.
-
A novel mutation in the cytochrome P450(27) (CYP27) gene caused cerebrotendinous xanthomatosis in a Japanese family.J Lipid Res. 1996 Mar;37(3):631-9. J Lipid Res. 1996. PMID: 8728324
-
Identification of new mutations in sterol 27-hydroxylase gene in Japanese patients with cerebrotendinous xanthomatosis (CTX).J Lipid Res. 1994 Jun;35(6):1031-9. J Lipid Res. 1994. PMID: 7915755
-
Cerebrotendinous xanthomatosis.Curr Opin Lipidol. 1994 Apr;5(2):138-42. doi: 10.1097/00041433-199404000-00010. Curr Opin Lipidol. 1994. PMID: 8044416 Review.
-
Clinical and molecular diagnosis of cerebrotendinous xanthomatosis with a review of the mutations in the CYP27A1 gene.Neurol Sci. 2006 Jun;27(2):143-9. doi: 10.1007/s10072-006-0618-7. Neurol Sci. 2006. PMID: 16816916 Review.
Cited by
-
Mutations producing premature termination of translation and an amino acid substitution in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis associated with parkinsonism.J Neurol Neurosurg Psychiatry. 1999 Aug;67(2):195-8. doi: 10.1136/jnnp.67.2.195. J Neurol Neurosurg Psychiatry. 1999. PMID: 10406988 Free PMC article.
-
Cerebrotendinous xanthomatosis in the Israeli Druze: molecular genetics and phenotypic characteristics.Am J Hum Genet. 1994 Nov;55(5):907-15. Am J Hum Genet. 1994. PMID: 7977352 Free PMC article.
-
Fine-mapping, mutation analyses, and structural mapping of cerebrotendinous xanthomatosis in U.S. pedigrees.J Lipid Res. 2001 Feb;42(2):159-69. J Lipid Res. 2001. PMID: 11181744 Free PMC article.
-
Anomalous enantioselectivity in the sharpless asymmetric dihydroxylation reaction of 24-nor-5beta-cholest-23-ene-3alpha,7alpha,12alpha-triol: synthesis of substrates for studies of cholesterol side-chain oxidation.Lipids. 1999 Apr;34(4):395-405. doi: 10.1007/s11745-999-0378-4. Lipids. 1999. PMID: 10443973
-
Newborn screening for cerebrotendinous xanthomatosis is the solution for early identification and treatment.J Lipid Res. 2018 Nov;59(11):2214-2222. doi: 10.1194/jlr.M087999. Epub 2018 Aug 22. J Lipid Res. 2018. PMID: 30135217 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources